Coherus Oncology (CHRS) Operating Margin Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3,724.00 |
| 10 | Coherus Oncology | 216.87 Mn | 49.83 Mn | 8.50 Mn | 30,424.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,424.00 |
| Dec 31, 2025 | 134,621.00 |
| Sep 30, 2025 | 39,108.00 |
| Jun 30, 2025 | -5,872.00 |
| Mar 31, 2025 | 233,914.00 |
| Dec 31, 2024 | -51,160.00 |
| Sep 30, 2024 | -73,130.00 |
| Jun 30, 2024 | -32,604.00 |
| Mar 31, 2024 | -272,819.00 |
| Dec 31, 2023 | 3,825.00 |
| Sep 30, 2023 | 13,418.00 |
| Jun 30, 2023 | 1,434.00 |
| Mar 31, 2023 | -7,424.00 |
| Dec 31, 2022 | -5,964.00 |
| Sep 30, 2022 | -13,737.00 |
| Jun 30, 2022 | -4,559.00 |
| Mar 31, 2022 | 6,694.00 |
| Dec 31, 2021 | -6,878.00 |
| Sep 30, 2021 | -6,943.00 |
| Jun 30, 2021 | -7,572.00 |
| Mar 31, 2021 | -23,673.00 |
| Dec 31, 2020 | -2,148.00 |
| Sep 30, 2020 | -1,672.00 |
| Jun 30, 2020 | 1,517.00 |
| Mar 31, 2020 | 7,992.00 |
| Jun 30, 2017 | -359,962.00 |
| Mar 31, 2017 | -4.45 Mn |
| Dec 31, 2016 | -819,186.00 |
| Sep 30, 2016 | 104,564.00 |
| Jun 30, 2016 | 41,183.00 |
| Mar 31, 2016 | 11,181.00 |
| Dec 31, 2015 | -10,288.00 |
| Sep 30, 2015 | -95,367.00 |
| Jun 30, 2015 | -49,649.00 |
| Mar 31, 2015 | -24,982.00 |
| Dec 31, 2014 | 44,216.00 |
| Sep 30, 2014 | 130,050.00 |